Philip G Kasprzyk Selected Research

2-ethylestradiol sulfamate

9/2008

2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip G Kasprzyk Research Topics

Disease

11	Neoplasms (Cancer) 02/2014 - 05/2004
4	Breast Neoplasms (Breast Cancer) 02/2014 - 08/2008
2	Prostatic Neoplasms (Prostate Cancer) 02/2014 - 09/2007
1	Multiple Myeloma 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Neutropenia 01/2013
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2008
1	Poisoning 07/2004

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 02/2014 - 09/2006
3	sulfamic acid (ammonium sulfamate)IBA 02/2014 - 09/2007
3	Hormones (Hormone)IBA 01/2013 - 09/2006
2	2- methoxyestradiol- 3,17- O,O- bis(sulfamate)IBA 01/2013 - 09/2008
2	cdc25 PhosphatasesIBA 03/2009 - 09/2005
1	7- methoxy- 2- (3- methoxybenzyl)- 6- sulfamoyloxy- 1,2,3,4- tetrahydroisoquinolineIBA 02/2014
1	1,2,3,4-tetrahydroisoquinolineIBA 02/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2013
1	2- (2,5- difluorophenyl)- 6- ((3- (methyl(3- ((2- methyl- 4,7- dioxo- 4,7- dihydro- 1,3- benzothiazol- 5- yl)amino)propyl)amino)propyl)amino)- 1,3- benzoxazole- 4,7- dioneIBA 03/2009
1	quinone (benzoquinone)IBA 03/2009
1	Angiogenesis InhibitorsIBA 09/2008
1	2- methoxyestradiol- 3,17- bis- O,O- sulfamateIBA 09/2008
1	2-ethylestradiol sulfamateIBA 09/2008
1	N- (2- fluoro- 4- (4- (2- (phenoxymethyl)- 1H- imidazol- 4- yl)phenoxy)phenyl)sulfamideIBA 08/2008
1	TubulinIBA 08/2008
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 09/2007
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 09/2007
1	Topoisomerase InhibitorsIBA 09/2006
1	BIM 46174IBA 09/2006
1	Cyclic AMP (AMP, Cyclic)IBA 09/2006
1	CalciumIBA 09/2006
1	Carrier Proteins (Binding Protein)IBA 09/2006
1	Cisplatin (Platino)FDA LinkGeneric 09/2006
1	GuanineIBA 09/2006
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2006
1	Neurotensin Receptors (Neurotensin Receptor)IBA 09/2006
1	Heterotrimeric GTP-Binding Proteins (Heterotrimeric G-Proteins)IBA 09/2006
1	Frizzled ReceptorsIBA 09/2006
1	Farnesyltranstransferase (Farnesyltransferase)IBA 09/2006
1	BN 82685IBA 09/2005
1	EnzymesIBA 09/2005
1	2-hydroxy-9-cis-octadecenoic acidIBA 02/2005
1	trioctyl phosphine oxide (TOPO)IBA 07/2004
1	homocamptothecinIBA 07/2004
1	AndrogensIBA 07/2004
1	DNA (Deoxyribonucleic Acid)IBA 07/2004
1	Proteins (Proteins, Gene)FDA Link 07/2004
1	BN82002IBA 05/2004

Therapy/Procedure

1	Therapeutics 03/2009
1	Withholding Treatment 09/2007